Elevated serum levels of free interleukin-18 in adult-onset Still's disease

Rheumatology (United Kingdom)

Volumn 55, Issue 12, 2016, Pages 2237-2247

  Girard, Charlotte ^a   Rech, Jürgen ^b   Brown, Michael ^c   Allali, Danièl ^a   Roux Lombard, Pascale ^a,d   Spertini, Françoi ^e   Schiffrin, Eduardo J ^f   Schett, Georg ^b   Manger, Bernhard ^b   Bas, Sylvette ^a,d   del Val, Greg ^f   Gabay, Cem ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Lyndin Group   (United States)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f EPFL   (Switzerland)

Author keywords

Adult onset Still's disease; Free IL 18; IL 18BP

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FERRITIN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RITUXIMAB; TOCILIZUMAB; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN-18 BINDING PROTEIN; PROTEIN BINDING; SIGNAL PEPTIDE;

ADULT; ADULT ONSET STILL DISEASE; ARTHRALGIA; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BINDING AFFINITY; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE RELEASE; DAS28; DISEASE ACTIVITY; DISEASE DURATION; DISEASE EXACERBATION; DISSOCIATION CONSTANT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; FEVER; HUMAN; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RASH; RHEUMATOID ARTHRITIS; SLEDAI; SORE THROAT; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; AGED; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; ALANINE TRANSAMINASE; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; LEUKOCYTOSIS; MALE; MIDDLE AGED; PROTEIN BINDING; STILL'S DISEASE, ADULT-ONSET;

EID: 85019796780     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kew300     Document Type: Article

References (43)

1. Bywaters EG. Still's disease in the adult. Ann Rheum Dis 1971;30:121-33.
2. Yamaguchi M, Ohta A, Tsunematsu T et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
3. Fautrel B, Le Moel G, Saint-Marcoux B et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol 2001;28:322-9.
4. Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Seve P. Adultonset Still's disease. Autoimmun Rev 2014;13:708-22.
5. Mavragani CP, Spyridakis EG, Koutsilieris M. Adult-onset Still's disease: from pathophysiology to targeted therapies. Int J Inflamm 2012;2012:879020.
6. Nakamura K, Okamura H, Wada M, Nagata K, Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infection Immun 1989;57:590-5.
7. Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol 2013;4:289.
8. Novick D, Kim SH, Fantuzzi G et al. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999;10:127-36.
9. Kim SH, Eisenstein M, Reznikov L et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000;97:1190-5.
10. Gracie JA, Forsey RJ, Chan WL et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999;104:1393-401.
11. Wong CK, Li EK, Ho CY, Lam CW. Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology 2000;39:1078-81.
12. Pietrzak A, Lecewicz-Torun B, Chodorowska G, Rolinski J. Interleukin-18 levels in the plasma of psoriatic patients correlate with the extent of skin lesions and the PASI score. Acta Derm Venereol 2003;83:262-5.
13. Shimizu M, Nakagishi Y, Yachie A. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine 2013;61:345-8.
14. Ichida H, Kawaguchi Y, Sugiura T et al. Clinical manifestations of adult-onset Still's disease presenting with erosive arthritis: association with low levels of ferritin and interleukin-18. Arthritis Care Res 2014;66:642-6.
15. Kawashima M, Yamamura M, Taniai M et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 2001;44:550-60.
16. Fujii T, Nojima T, Yasuoka H et al. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology 2001;40:1398-404.
17. Kawaguchi Y, Terajima H, Harigai M, Hara M, Kamatani N. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease. Arthritis Rheum 2001;44:1716-7.
18. Choi JH, Suh CH, Lee YM et al. Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol 2003;30:2422-7.
19. Chen DY, Lan JL, Lin FJ, Hsieh TY, Wen MC. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease. Ann Rheum Dis 2004;63:1300-6.
20. Saiki O, Uda H, Nishimoto N et al. Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile. Clin Immunol 2004;112:120-5.
21. Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol 2004;31:2189-98.
22. Priori R, Barone F, Alessandri C et al. Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis. Rheumatology 2011;50:776-80.
23. Colafrancesco S, Priori R, Alessandri C et al. IL-18 serum level in adult onset Still's disease: a marker of disease activity. Int J Inflamm 2012;2012:156890.
24. Jung KH, Kim JJ, Lee JS et al. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease. Scand J Rheumatol 2014;43:162-9.
25. Priori R, Colafrancesco S, Alessandri C et al. Interleukin 18: a biomarker for differential diagnosis between adultonset Still's disease and sepsis. J Rheumatol 2014;41:1118-23.
26. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
27. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
28. Rudwaleit M, van der Heijde D, Landewe R et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-83.
29. Taylor W, Gladman D, Helliwell P et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
30. Fransen JWelsing PDe Keijzer RVan Riel P. Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 2003;62(Suppl 1):151.
31. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
32. Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
33. Novick D, Schwartsburd B, Pinkus R et al. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 2001;14:334-42.
34. Shimizu M, Nakagishi Y, Inoue N et al. Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Clin Immunol 2015;160:277-81.
35. Chen O, Shan N, Zhu X et al. The imbalance of IL-18/IL- 18BP in patients with systemic juvenile idiopathic arthritis. Acta Biochim Biophys Sin (Shanghai) 2013;45:339-41.
36. Mazodier K, Marin V, Novick D et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 2005;106:3483-9.
37. Muhl H, Kampfer H, Bosmann M et al. Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun 2000;267:960-3.
38. Hoshino T, Ohta A, Yang D et al. Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factoralpha levels in patients with adult Still's disease. J Rheumatol 1998;25:396-8.
39. Yoshimoto T, Takeda K, Tanaka T et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 1998;161:3400-7.
40. Gu Y, Kuida K, Tsutsui H et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997;275:206-9.
41. Palomo J, Dietrich D, Martin P, Palmer G, Gabay C. The interleukin (IL)-1 cytokine family-balance between agonists and antagonists in inflammatory diseases. Cytokine 2015;76:25-37.
42. Canna SW, de Jesus AA, Gouni S et al. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet 2014;46:1140-6.
43. Romberg N, Al Moussawi K, Nelson-Williams C et al. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet 2014;46:1135-9.